Market revenue in 2023 | USD 271.8 million |
Market revenue in 2030 | USD 559.2 million |
Growth rate | 10.9% (CAGR from 2023 to 2030) |
Largest segment | Test kits |
Fastest growing segment | Test Kits |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Test Kits, Readers |
Key market players worldwide | Zoetis Inc Class A, IDEXX Laboratories Inc, Virbac SA, Mars Group Holdings Corp, Thermo Fisher Scientific Inc, Neogen Corp, Merck & Co Inc, Bosterbio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary rapid test market will help companies and investors design strategic landscapes.
Test kits was the largest segment with a revenue share of 80.21% in 2023. Horizon Databook has segmented the U.S. veterinary rapid test market based on test kits, readers covering the revenue growth of each sub-segment from 2018 to 2030.
The key driver for the U.S. market is the increasing adoption of diagnostic testing due to coverage under pet insurance.
Typically, in the U.S., health insurance for pets covers diagnostic testing such as X-rays, MRI, and blood work.
Data by Forbes on January 3, 2024, covered the average pet insurance cost in the US and its coverage.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary rapid test market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary rapid test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account